Saturday, October 3, 2026

USD/EUR Is 2% Down In The Last 21 Sessions

USD/EUR Is 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.03% for the last 21 sessions. At 10:08 EST on Monday, 3 July, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 1.531% up from its 52-week low and 12.688% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.07%, a negative 0.06%, and a positive 0.35%, respectively.

USD/EUR's highest amplitude of average volatility was 0.26% (last week), 0.35% (last month), and 0.35% (last quarter), respectively.

News about

  • Eur/usd to be around the 1.15 level by the end of next year – bofa. According to FXStreet on Monday, 3 July, "Economists at the Bank of America expect the EUR/USD pair to hover around 1.15 by the end of 2024.", "Beyond that, we predict that EUR/USD will move towards its fair value in the 1.20s."
  • According to FXStreet on Monday, 3 July, "At the start of the new trading week, the Euro (EUR) is under noticeable pressure, retracing part of Friday's strong gains and forcing EUR/USD to drop below the key support level of 1.0900 the figure.", "The constructive view of EUR/USD appears unchanged as long as the pair trades above the crucial 200-day SMA, today at 1.0595."
  • According to FXStreet on Monday, 3 July, "In the FX market, the region should benefit today with a delay from Friday's upward movement of EUR/USD as well as the positive sentiment in Europe from the end of last week. "
  • Eur/usd grinds higher past 1.0900 ahead of fed minutes, NFP. According to FXStreet on Sunday, 2 July, "A daily closing beyond a downward-sloping resistance line from June 22, close to 1.0920 by the press time, becomes necessary for the EUR/USD bulls to retake control.", "Hence, EUR/USD traders may witness hardships in extending the latest recovery should this week's Federal Open Market Committee(FOMC)Monetary policy meeting Minutes and the US jobs report offer upbeat signals. "
  • Eur/usd struggles for a firm intraday direction, consolidates in a range above 1.0900 mark. According to FXStreet on Monday, 3 July, "The EUR/USD pair struggles to gain any meaningful traction on the first day of the new week and oscillates in a narrow trading band through the Asian session. ", "The shared currency continues to draw some support from rising bets for another 25 bps lift-off by the European Central Bank (ECB) in July and turns out to be a key factor lending some support to the EUR/USD pair. "

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com